Search research articles
Contact Us
Filters
Showing results (531-540 of 658) with videos related to
Page
of 66
Sort By:
The Journal of Experimental Medicine
|
April 2, 2008
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity
Elizabeth E Forbes, Katherine Groschwitz, J Pablo Abonia, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 18, 2024
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis
Silvio Danese, Michael E Rothenberg, Jeremy J Lim, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
June 27, 2007
Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis
Jennifer Z Bullock, Joyce M Villanueva, Carine Blanchard, et al.
The Journal of Allergy and Clinical Immunology
|
December 31, 2003
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes
Jennifer K Garrett, Sean C Jameson, Blythe Thomson, et al.
JCI Insight
|
April 28, 2026
IL-13 and calpain-14 suppress the expression of SPINK7 by regulating OVOL1 in eosinophilic esophagitis
Nurit P Azouz, Andrea M Klingler, Sierra S Beach, et al.
The Journal of Allergy and Clinical Immunology
|
January 30, 2007
Pediatric patients with eosinophilic esophagitis: an 8-year follow-up
Amal H Assa'ad, Philip E Putnam, Margaret H Collins, et al.
The Journal of Clinical Investigation
|
September 23, 2025
Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice
Yrina Rochman, Michael Kotliar, Andrea M Klingler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 5, 2008
Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis
Richard Ahrens, Amanda Waddell, Luqman Seidu, et al.
Environmental Health Perspectives
|
December 28, 2020
Community Approaches for Integrating Environmental Exposures into Human Models of Disease
Anne E Thessen, Cynthia J Grondin, Resham D Kulkarni, et al.
Gastroenterology
|
April 29, 2014
Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis
Bridget K Butz, Ting Wen, Gerald J Gleich, et al.
Page
of 66
Search research articles
Search
Showing results (531-540 of 658) with videos related to
Sort By:
Page
of 66
The Journal of Experimental Medicine
|
April 2, 2008
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity
Elizabeth E Forbes, Katherine Groschwitz, J Pablo Abonia, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 18, 2024
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis
Silvio Danese, Michael E Rothenberg, Jeremy J Lim, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
June 27, 2007
Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis
Jennifer Z Bullock, Joyce M Villanueva, Carine Blanchard, et al.
The Journal of Allergy and Clinical Immunology
|
December 31, 2003
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes
Jennifer K Garrett, Sean C Jameson, Blythe Thomson, et al.
JCI Insight
|
April 28, 2026
IL-13 and calpain-14 suppress the expression of SPINK7 by regulating OVOL1 in eosinophilic esophagitis
Nurit P Azouz, Andrea M Klingler, Sierra S Beach, et al.
The Journal of Allergy and Clinical Immunology
|
January 30, 2007
Pediatric patients with eosinophilic esophagitis: an 8-year follow-up
Amal H Assa'ad, Philip E Putnam, Margaret H Collins, et al.
The Journal of Clinical Investigation
|
September 23, 2025
Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice
Yrina Rochman, Michael Kotliar, Andrea M Klingler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 5, 2008
Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis
Richard Ahrens, Amanda Waddell, Luqman Seidu, et al.
Environmental Health Perspectives
|
December 28, 2020
Community Approaches for Integrating Environmental Exposures into Human Models of Disease
Anne E Thessen, Cynthia J Grondin, Resham D Kulkarni, et al.
Gastroenterology
|
April 29, 2014
Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis
Bridget K Butz, Ting Wen, Gerald J Gleich, et al.
Page
of 66